Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
EIF2S1 (phospho S51) Rabbit anti-Human, Clone:RM298, Abnova™
Rabbit monoclonal antibody raised against human EIF2S1 (phospho S51).
Supplier: Abnova Corporation MAB16924
Description
The translation initiation factor eIF2 catalyzes the first regulated step of protein synthesis initiation, promoting the binding of the initiator tRNA to 40S ribosomal subunits. Binding occurs as a ternary complex of methionyl-tRNA, eIF2, and GTP. eIF2 is composed of 3 nonidentical subunits, alpha (36 kD), beta (38 kD, MIM 603908), and gamma (52 kD, MIM 300161). The rate of formation of the ternary complex is modulated by the phosphorylation state of eIF2-alpha (Ernst et al., 1987 [PubMed 2948954]).[supplied by OMIM]Specifications
EIF2S1 (phospho S51) | |
Monoclonal | |
Unconjugated | |
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1:100-200) Western Blot (1:100-200) The optimal working dilution should be determined by the end user. |
|
EIF2S1 | |
Rabbit | |
100 μL | |
This antibody reacts to human eIF-2α (eukaryotic translation initiation factor 2 subunit alpha) only when phosphorylated at Ser51. There is no cross-reactivity to eIF-2α not phosphorylated at Ser51. This antibody may also react to mouse or rat Phospho-eIF-2α (Ser51), as predicted by immunogen homology. | |
Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
|
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
RM298 | |
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa | |
In PBS (50% glycerol, 1% BSA, 0.09% sodium azide) | |
EIF-2, EIF-2A, EIF-2alpha, EIF2, EIF2A | |
A phospho-peptide corresponding to human EIF2S1 (phospho S51). | |
1965 | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction